PIL against 10 top pharma Cos in SC alleging sale of Remdesivir and Favipiravir without valid license Ruchika Sharma7 Sept 2020 1:26 PM ISTIt has also made 10 pharmaceutical companies, including Cipla Ltd, Dr Reddy's Laboratories Ltd, Hetero Labs Ltd and Zydus Cadila Healthcare Ltd,...
Pfizer teams up with Gilead to help manufacture Covid drug remdesivir Ruchika Sharma10 Aug 2020 12:38 PM ISTUS: Pfizer Inc (PFE.N) said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc...
AbbVie, Amgen, Takeda Pharma launch joint trial of coronavirus medicines Ruchika Sharma4 Aug 2020 10:45 AM ISTUS: Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly...
COVID-19: One in three South Korean patients showed improvement with Remdesivir Ruchika Sharma14 July 2020 10:45 AM ISTNine of the patients showed an improvement in their condition, 15 showed no change, and three worsened, KCDC deputy director Kwon Jun-wook told a...
Remdesivir reduced risk of death in Covid-19 patients, more studies needed: Gilead Ruchika Sharma12 July 2020 10:15 AM ISTGilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with...
Gilead Sciences condemned for pricing coronavirus drug at USD 2340 Ruchika Sharma30 Jun 2020 10:45 AM ISTBut recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between USD 2,520 and USD 2,800, the...
Cipla to knock out Hetero Healthcare in pricing battle of Remdesivir? Farhat Nasim29 Jun 2020 5:13 PM ISTNew Delhi: Igniting drug pricing battle among pharmaceutical majors, Drug major, Cipla Ltd., has priced antiviral drug Remdesivir at under Rs...
Dr Reddy's, Gilead enter licensing pact for investigational COVID drug Remdesivir Ruchika Sharma15 Jun 2020 11:35 AM ISTDr. Reddy’s will receive technology transfer from Gilead for the manufacturing of this drug.
Zydus Cadila, Gilead ink licensing agreement to manufacture, market Remdesivir Ruchika Sharma13 Jun 2020 11:25 AM ISTUnder the agreement, the license is royalty-free until another pharmaceutical product or vaccine is approved for the treatment or prevention of COVID...
DCGI nod to Gilead Sciences Remdesivir to treat COVID-19 cases in India Farhat Nasim3 Jun 2020 10:58 AM ISTRemdesivir has been allowed for restricted emergency use for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and...
Gilead's remdesivir shows modest improvement in moderate COVID-19 patients Dr. Kamal Kant Kohli2 Jun 2020 6:29 PM ISTGilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a...
CDSCO shows green flag to Gilead Sciences to market COVID-19 drug Remdesivir Ruchika Sharma2 Jun 2020 11:50 AM IST"The drug, which is administered in the form of an injection, has been approved to be sold by retail on the prescription of specialists for use in the...
